drugset / Trial / NCT03034057

Sayana Press UK Self-Injection Study

NCT03034057

Phase 4 Completed 169 enrolled Pfizer
Parallel-groupOpen-labelPrevention

Summary

A one-year evaluation of Sayana Press self injection in women of reproductive age in the United Kingdom (UK).

Timeline

Start
2017-08-23
Primary completion
2018-12-07
Completion
2018-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject medroxyprogesterone acetate Other / unclassified

Indications

No indication recorded.